TNF stimulates IL-6, CXCL8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TNF stimulates IL-6, CXCL8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin
Authors
Keywords
-
Journal
EXPERIMENTAL DERMATOLOGY
Volume 27, Issue 2, Pages 135-143
Publisher
Wiley
Online
2017-11-04
DOI
10.1111/exd.13461
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuroendocrinology of mast cells: Challenges and controversies
- (2017) Theoharis C. Theoharides EXPERIMENTAL DERMATOLOGY
- Psoriasis - What′s Up ?
- (2017) Mona Ståhle et al. EXPERIMENTAL DERMATOLOGY
- Skin mast cell phenotypes between two highly divergent cohorts - more pronounced variability within than between groups
- (2017) Magda Babina et al. EXPERIMENTAL DERMATOLOGY
- IL-17F regulates psoriasis-associated genes through IκBζ
- (2017) Trine Bertelsen et al. EXPERIMENTAL DERMATOLOGY
- Differential regulation of surface receptor expression, proliferation, and apoptosis in HaCaT cells stimulated with interferon-γ, interleukin-4, tumor necrosis factor-α, or muramyl dipeptide
- (2017) Emale El Darzi et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Tolerability and benefit of a tetramethoxyluteolin-containing skin lotion
- (2017) Theoharis C Theoharides et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- IL-33 in clinical practice: Size matters?
- (2017) Hideaki Morita et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis
- (2017) Andrew Johnston et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Methoxyluteolin Inhibits Neuropeptide-stimulated Proinflammatory Mediator Release via mTOR Activation from Human Mast Cells
- (2017) Arti B. Patel et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors
- (2017) Alexandra Taracanova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proinflammatory Cytokine Production in HaCat Cells Treated by Eosin: Implications for the Topical Treatment of Psoriasis
- (2017) A. Zampetti et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Meta-analysis of the Efficacy and Safety of Secukinumab for the Treatment of Plaque Psoriasis
- (2016) Ju Yeon Ryoo et al. ANNALS OF PHARMACOTHERAPY
- Short-term efficacy and safety of new biological agents targeting the interleukin-23-T helper 17 pathway for moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis
- (2016) F. Gómez-García et al. BRITISH JOURNAL OF DERMATOLOGY
- IgE and FcεRI are highly expressed on innate cells in psoriasis
- (2016) K-X. Yan et al. BRITISH JOURNAL OF DERMATOLOGY
- Association between plasma interleukin-17 levels and risk of psoriasis: a meta-analysis
- (2016) X. Y. Zhou et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- The Inflammatory Response in Psoriasis: a Comprehensive Review
- (2016) Yaxiong Deng et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Flavonoid myricetin inhibits TNF-α-stimulated production of inflammatory mediators by suppressing the Akt, mTOR and NF-κB pathways in human keratinocytes
- (2016) Da Hee Lee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effects of mammalian target of rapamycin inhibitors on cytokine production and differentiation in keratinocytes
- (2016) Viola DeTemple et al. EXPERIMENTAL DERMATOLOGY
- Skin mast cells: are we missing the forest for the trees?
- (2016) Theoharis C. Theoharides EXPERIMENTAL DERMATOLOGY
- Novel topical treatments for psoriasis: of interest or irrelevant?
- (2016) Natalie Garzorz et al. EXPERIMENTAL DERMATOLOGY
- Phenotypic variability in human skin mast cells
- (2016) Magda Babina et al. EXPERIMENTAL DERMATOLOGY
- Novel investigational vascular endothelial growth factor (VEGF) receptor antagonists for psoriasis
- (2016) N. Malecic et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- IL-17A plays a central role in the expression of psoriasis signature genes through the induction of IκB-ζ in keratinocytes
- (2016) Ryuta Muromoto et al. INTERNATIONAL IMMUNOLOGY
- Characterization of TNF-α– and IL-17A–Mediated Synergistic Induction of DEFB4 Gene Expression in Human Keratinocytes through IκBζ
- (2016) Claus Johansen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Neuroendocrinology of the skin
- (2016) Theoharis C. Theoharides et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Serum IL-33 levels are increased in patients with psoriasis
- (2015) A. Mitsui et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17
- (2015) Lynda Grine et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Combination therapy of cyclosporine and anti-tumor necrosis factor α in psoriasis: a case series of 10 patients
- (2015) Eran Cohen Barak et al. Dermatologic Therapy
- The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells
- (2015) Zuyi Weng et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cutaneous adverse effects of targeted therapies
- (2015) James B. Macdonald et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Evaluating the economic burden of psoriasis in the United States
- (2015) Jacqueline Vanderpuye-Orgle et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- Mast Cells, Mastocytosis, and Related Disorders
- (2015) Theoharis C. Theoharides et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of mTORC1 by PI3K signaling
- (2015) Christian C. Dibble et al. TRENDS IN CELL BIOLOGY
- Economic Burden of Psoriasis in the United States
- (2015) Elizabeth A. Brezinski et al. JAMA Dermatology
- Phosphoinositide-3 Kinase/Protein Kinase-B/Mammalian Target of Rapamycin Pathway in Psoriasis Pathogenesis. A Potential Therapeutic Target?
- (2014) T Huang et al. ACTA DERMATO-VENEREOLOGICA
- Prevalence of Psoriasis Among Adults in the U.S.
- (2014) Charles G. Helmick et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- The IL-23/IL-17 axis in psoriatic arthritis
- (2014) Erika Suzuki et al. AUTOIMMUNITY REVIEWS
- TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants – past, present and future
- (2014) Lisa M. Sedger et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Combination of everolimus and tacrolimus: a potentially effective regimen for recalcitrant psoriasis
- (2014) Kai-Che Wei et al. Dermatologic Therapy
- Nerve growth factor regulates the expression of vascular endothelial growth factor in human HaCaT keratinocytes via PI3K/mTOR pathway
- (2014) J. Zhang et al. GENETICS AND MOLECULAR RESEARCH
- Activation and Function of the mTORC1 Pathway in Mast Cells
- (2014) M.-S. Kim et al. JOURNAL OF IMMUNOLOGY
- Luteolin Inhibits Human Keratinocyte Activation and Decreases NF-κB Induction That Is Increased in Psoriatic Skin
- (2014) Zuyi Weng et al. PLoS One
- Intersection of population variation and autoimmunity genetics in human T cell activation
- (2014) C. J. Ye et al. SCIENCE
- Current and potential immune therapies and vaccines in the management of psoriasis
- (2014) Benjamin H Kaffenberger et al. Human Vaccines & Immunotherapeutics
- Inhibition of Akt/mTOR Signaling by the Dietary Flavonoid Fisetin
- (2013) Deeba Syed et al. Anti-Cancer Agents in Medicinal Chemistry
- Mammalian target of rapamycin and its downstream signalling components are activated in psoriatic skin
- (2013) C. Buerger et al. BRITISH JOURNAL OF DERMATOLOGY
- The effect of neurotensin in human keratinocytes – implication on impaired wound healing in diabetes
- (2013) Liane IF Moura et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis
- (2013) Bruce W. Kirkham et al. IMMUNOLOGY
- 1α,25-Dihydroxyvitamin-D3-3-Bromoacetate Regulates AKT/mTOR Signaling Cascades: A Therapeutic Agent for Psoriasis
- (2013) Ananya Datta Mitra et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Keratinocytes express cytokines and nerve growth factor in response to neuropeptide activation of the ERK1/2 and JNK MAPK transcription pathways
- (2013) Xiaoyou Shi et al. REGULATORY PEPTIDES
- mTOR signaling cascade in psoriatic disease: Double kinase mtor inhibitor a novel therapeutic target
- (2013) SibaR Raychaudhuri et al. INDIAN JOURNAL OF DERMATOLOGY
- Dietary flavonoid fisetin: A novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management
- (2012) Vaqar Mustafa Adhami et al. BIOCHEMICAL PHARMACOLOGY
- Serum neurotensin (NT) is increased in psoriasis and NT induces vascular endothelial growth factor release from human mast cells
- (2012) M. Vasiadi et al. BRITISH JOURNAL OF DERMATOLOGY
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade
- (2012) Anupam Mitra et al. CYTOKINE
- IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation
- (2012) Anna Balato et al. EXPERIMENTAL DERMATOLOGY
- The roles of cells and cytokines in the pathogenesis of psoriasis
- (2012) Susana Coimbra et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Increased serum CRH levels with decreased skin CRHR-1 gene expression in psoriasis and atopic dermatitis
- (2012) Magdalini Vasiadi et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin
- (2012) Shahrzad Asadi et al. Journal of Neuroinflammation
- Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
- (2012) Lam C Tsoi et al. NATURE GENETICS
- The PI3-Kinase/mTOR-Targeting Drug NVP-BEZ235 Inhibits Growth and IgE-Dependent Activation of Human Mast Cells and Basophils
- (2012) Katharina Blatt et al. PLoS One
- Neurotensin and CRH Interactions Augment Human Mast Cell Activation
- (2012) Konstantinos–Dionysios Alysandratos et al. PLoS One
- Neuropeptides Contribute to Peripheral Nociceptive Sensitization by Regulating Interleukin-1β Production in Keratinocytes
- (2011) Xiaoyou Shi et al. ANESTHESIA AND ANALGESIA
- mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells
- (2011) D. Smrz et al. BLOOD
- Production of IL-6 by Keratinocytes
- (2010) THOMAS S. KUPPER et al. Annals of the New York Academy of Sciences
- Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis—A possible target for novel therapies?
- (2010) Miriam Canavese et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Substance P downregulates expression of the high affinity IgE receptor (FcεRI) by human mast cells
- (2010) Christine McCary et al. JOURNAL OF NEUROIMMUNOLOGY
- The dual nature of TH17 cells: shifting the focus to function
- (2010) William O'Connor et al. NATURE IMMUNOLOGY
- IL-33 Is Produced by Mast Cells and Regulates IgE-Dependent Inflammation
- (2010) Chia-Lin Hsu et al. PLoS One
- IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin
- (2010) T. C. Theoharides et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The expression and phosphorylation of eukaryotic initiation factor 4E are increased in lesional psoriatic skin
- (2009) R.B. Kjellerup et al. BRITISH JOURNAL OF DERMATOLOGY
- Innate immunity and allergy in the skin
- (2009) Martin Metz et al. CURRENT OPINION IN IMMUNOLOGY
- Treatment strategies for early psoriatic arthritis
- (2009) Ignazio Olivieri et al. EXPERT OPINION ON PHARMACOTHERAPY
- Psoriasis market
- (2009) Irena Melnikova NATURE REVIEWS DRUG DISCOVERY
- Psoriasis
- (2009) Frank O. Nestle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Is there a role for mast cells in psoriasis?
- (2008) Ilkka T. Harvima et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells
- (2008) D Kempuraj et al. BRITISH JOURNAL OF PHARMACOLOGY
- Akt-dependent regulation of NF- B is controlled by mTOR and Raptor in association with IKK
- (2008) H. C. Dan et al. GENES & DEVELOPMENT
- Reactive Oxygen Species in Tumor Necrosis Factor-α-Activated Primary Human Keratinocytes: Implications for Psoriasis and Inflammatory Skin Disease
- (2008) Chen N. Young et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Neuropeptides activate human mast cell degranulation and chemokine production
- (2007) Marianna Kulka et al. IMMUNOLOGY
- Differential Expression of D-Type Cyclins in HaCaT Keratinocytes and in Psoriasis
- (2007) Nóra Belsõ et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now